Revolutionizing Prostate Cancer Diagnosis Urine Testing Insights with Dr David Albala - [EP-111]

#ProstateCancer #Genomics #CancerDiagnosis #ExoDx #PSATest #Biomarkers #4Kscore #prostatehealth
Join Dr. Geo as he interviews Dr. David Albala, Chief of Urology at Crouse Hospital and a renowned expert in laparoscopic and robotic urological surgery. They explore the advancements in prostate cancer diagnosis, emphasizing the shift from routine biopsies based on high PSA levels to more sophisticated methods like urine tests and biomarkers such as free PSA, ExoDx, and 4Kscore. Dr. Albala shares his experiences and insights on the benefits and limitations of these tests, reflecting on how telemedicine and technological advancements are improving patient outcomes.

In this episode, Dr. Albala discusses the evolution of prostate cancer surgeries from open and laparoscopic to robotic techniques, highlighting the importance of minimally invasive procedures. He emphasizes the role of patient education and shared decision-making in prostate cancer treatment, sharing his reflections on his career and contributions to the field.

📚 Chapters
00:00 Revolutionizing Prostate Cancer Diagnosis Urine Testing Insights
01:23 The Importance of Patient Education
11:11 The Role of Digital Rectal Exams
14:25 The Future of Prostate Cancer Diagnosis
15:09 Exploring Biomarkers for Prostate Cancer
24:57 Advancements in BPH Treatments
35:58 Innovative At-Home Prostate Testing
37:36 Telehealth and Prostate Health
38:02 Understanding Exosome Test Results
42:24 The Role of Physical Exams in Prostate Cancer Detection
45:01 The Evolution of Prostate Surgery
01:00:46 Laparoscopic vs. Robotic Surgery

----------------
📌Thank You To Our July Sponsors:

The Decipher Test: The Decipher Prostate Test by Veracyte analyzes specific genes in a prostate tumor to assess cancer aggressiveness, aiding in personalized treatment decisions and improving patient outcomes. Learn more about the Decipher Prostate Test here [https://bit.ly/4cNH805].

ExoDx: The ExoDx Prostate Score is a non-invasive urine test for assessing the risk of aggressive prostate cancer, using cancer-specific genomic biomarkers. Scores below 15.6 indicate low risk, while scores above 15.6 indicate higher risk. Decisions on further actions, such as biopsies, should involve shared decision-making between the doctor and patient. Learn more about ExoDx here [https://bit.ly/3oA8rXC].

XY Wellness: XY Wellness provides a high-value roadmap to health and wellness for men with prostate cancer. Co-founded by our Chief Medical Officer, they aim to help men thrive post-diagnosis. [Learn more about XY Wellness here [https://bit.ly/3uJPC7Z].

📕 Get Dr. Geo’s FreeEbook- A Guide to Improve Prostate Problems Naturally https://bit.ly/DRGEOFreeEbook

📌Thank You To Our Sponsors
AG1 (Athletic Greens): https://bit.ly/3mA2tVV
AG1 by Athletic Greens, sponsoring this episode, offers a comprehensive blend of 75 vitamins, minerals, whole foods, probiotics, and adaptogens to support gut health, the nervous system, immunity, energy, recovery, focus, and aging.

📌 Dr. Geo’s Social Media and Websites

Instagram: https://bit.ly/DRGEO-INSTA-YT
Facebook: https://bit.ly/POD-FB-DrGeo
LinkedIn: https://bit.ly/DRGEO-LINKEDIN-YT
Website: https://bit.ly/43khht0
XY Wellness- Prostate Health Supplements - https://bit.ly/3uJPC7Z
Mr. Happy- Supplements for Men- https://bit.ly/3RJMX6O

#decipher #genomics #genetherapy
#


______________________________________________________________________
DISCLAIMER: This audio is educational and does not constitute medical advice. This audio's content is my opinion, not that of my employer(s) or any affiliated company.
Use of this information is at your own risk. Geovanni Espinosa, N.D., will not assume any liability for any direct or indirect losses or damages resulting from using the information in this video, including but not limited to economic loss, injury, illness, or death.